Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1350)	6/29/2015 8:49:17 PM
From: phoenix_rising	Respond to of 2026

Ok, well that is pretty clear. Was surprised how well APRI held up in last night's bloodbath. I saw it down to $1.59 and tried to get in there, but by the time I got my trading platform open, it was up to $1.63. Still picked up a few more shares as I can't see us staying below $2 for much longer once the results for RayVa come out officially and we get some feedback on how Fispemifene trials are going.